← Back to Search

Artificial Intelligence

Experimental Group In-person expert-mediated instruction group for Surgical Education

N/A
Waitlist Available
Led By Rolando Del Maestro, MD
Research Sponsored by McGill University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Medical students who are actively enrolled in medical school in any Canadian institution who do not meet the
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day of study
Awards & highlights

Study Summary

Background: Trainees learn surgical technical skills through apprenticeship model working closely with surgeons and given increased responsibility in patient cases under expert supervision. However, factors such as surgeons' busy schedule, number of available patient cases, patient safety and lack of objectivity and standardization in training pose strong limitations. Virtual reality surgical simulators integrated with artificial intelligence (AI) systems provide a standardized realistic simulation environment and detailed performance data that allows accurate quantitation of surgical skills and tailored feedback. These platforms make repetitive practice of surgical skills possible in a risk-free environment. The Intelligent Continuous Monitoring System (ICEMS), a deep learning application integrated in NeuroVR simulation platform, was developed to assess surgical performance continuously in 0.2 second intervals and provide coaching and risk detection. Although a predictive validity for assessment module was provided previously, the effectiveness of real-time coaching and risk detection ability with this AI system remains to be explored. The objective of this study is to compare the error-oriented intelligent feedback provided by the ICEMS to in-person expert instruction in surgical simulation training by monitoring the improvement of medical student technical skills on a series of virtual reality tumor resection tasks.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day of study
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 day of study for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in performance
Transfer of learning
Secondary outcome measures
Difference in Cognitive Load
Differences in strength of emotions elicited
Objective Structured Assessment of Technical Skills (OSATS) global rating scale

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Experimental Group In-person expert-mediated instruction groupExperimental Treatment1 Intervention
30 Participants. Introductory information provided on simulator and scenario. They perform 5 simple practice subpial tumor resections with 5 minutes per trial. On 6th attempt 13 minutes to perform a complex realistic scenario. During first practice task participants receive no feedback. For the subsequent 4 practice tasks participants receive real-time auditory feedback instruction by in-person expert during the task. After each of the 5 tasks, students takes a 5-minute break. During each of the 5 breaks the in-person expert provides feedback to the participant based on their OSATS score assessment during the previous trial. If the expert feels it is appropriate the expert will demonstrate how to do the specific procedure which has been found to be a concern on the simulator themselves so the participant can understand how to improve their performance. On their 6th attempt they will perform on the realistic scenario without any feedback given.
Group II: Experimental Group - Intelligent Continuous Expertise Monitoring System groupExperimental Treatment1 Intervention
30 Participants. Introductory information provided on simulator and scenario. They perform 5 simple practice subpial tumor resections with 5 minutes per trial. On 6th attempt 13 minutes to perform a complex realistic scenario. During first practice task, participants receive no feedback. For the subsequent 4 practice tasks participants will receive real-time auditory feedback instruction by the intelligent system. After each of the 5 attempts, a student takes a 5-minute break. During each of the 5 breaks the participants will be shown the errors they made during the task by the intelligent system regarding five performance metrics monitored. After seeing each error outline, the participant will be shown a video demonstration to learn how to expertly perform on each performance metric. On their 6th attempt they will perform on the realistic scenario without any feedback given.
Group III: Control Group No-expert mediated post hoc benchmark groupActive Control1 Intervention
30 participants. Individuals receive identical introductory information,same time, to perform, same scenarios as other groups. Students receive their scores on 5 performance metrics compared to expert performance benchmarks. Scores are presented in the 5 minute breaks between tasks. Student goal is to be within the benchmark in all five metrics.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Experimental: Experimental Group - Intelligent Continuous Expertise Monitoring System group
2022
N/A
~100
Experimental Group In-person expert-mediated instruction group
2022
N/A
~100

Find a Location

Who is running the clinical trial?

McGill UniversityLead Sponsor
392 Previous Clinical Trials
984,409 Total Patients Enrolled
3 Trials studying Surgical Education
277 Patients Enrolled for Surgical Education
Rolando Del Maestro, MDPrincipal InvestigatorMcGill
1 Previous Clinical Trials
70 Total Patients Enrolled
1 Trials studying Surgical Education
70 Patients Enrolled for Surgical Education

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~31 spots leftby Mar 2025